Dr Datsons Labs to receive “Transformational Come Back Company of the year”

Dr. Datsons Labs to receive “Transformational & Come Back Company of the year” for sustained healthcare innovations

Dr. Datsons Labs bounces back with transformation in healthcare excellence, voted as “Transformational & Come Back Company of the year” at Historic 7^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2014

Thursday, 27^th November, 2014, Mumbai, Maharashtra. Mumbai based Pharmaceutical & Research Driven Pharma major received a feather in its cap as “Transformational & Come Back Company of the year” for its sustained healthcare innovations at  the Pharmaleaders Power Brand 2014 ( www.pharmaleaders2014.in ) with a coveted nomination in selection as at the Historic 7^th Annual Pharmaceutical Leadership Summit & Business Leadership awards 2014 in a uniquely positioned full day program encompassing two themes “Make In India – Healthcare Reforms , Insurance,Innovations,Investments & Infrastructure” & Empowering India’s Developing Healthcare System - Investing the Healthcare Solutions of Tomorrow in difficult Times at the Sahara Star, Mumbai International Airport in Mumbai, India, on December,26th , 2014. This  historic Summit is supported by the Government of India at the Centre & is actively supported  by the Ministry of Health &  Family Affairs, Govt of India, Ministry of Commerce Pharmaceuticals , Government of india & host of other trade bodies.

Pharma Leaders™ , asia’s biggest media in healthcare communications in association with Network 7 Media Group undertook the gigantic task of identifying the Leader in Healthcare Innovations as it has been doing for years. The Primary factor that propelled the Jury to select Dr Datsons Labs is to look at the forward looking vision of the company coupled with the risk taking abilities & the visionary Leadership of steering the company in the complex business of healthcare where each day we are witnessing new competition, bigger challenges & ability to stay ahead of competition.

While selecting the Award, Pharmaleaders observed that behind every great entrepreneur is a great comeback story. The most successful people have had some of the greatest failures--and then bounced back. Which brings us back to Pharmaleader’s most influential list and what it says about the Indian way of innovation. It further stated that “one can be fired, or stare into the abyss of bankruptcy or even serve time. But if one has  the grit to get back into the game, you get a second chance-;humbler, wiser and better able to compete. Turnarounds of the magnitude that are occurring at Indian Companies are no simple, quick, or easy thing. But these comebacks have three things in common, and each element is required for success & Accepting that disruption in their industries has created a new height.Repositioning the core business, even if it means getting smaller. Pharmaleaders further stated in a communication to Dr datsons “even if you were hit by global economy meltdown & stock market crash, but you bounced bank & embarked on a strategic plan of retooling the old while inventing new growth opportunities based on fresh insights about customer needs. The Jury took these factors for the final selection”.

Appreciating the Award selection at a very crucial time, Dr. Kannan Vishwanath, Vice Chairman & Managing Director of Dr datsons Labs Ltd said” Dr Datsons Labs always believed in bringing path breaking innovations in its business model & its latest foray in getting clients in developed markets will add revenues to its kitty to be utlilized for the state of the art technology at UK-MHRA and EU-GMP-compliant facilities, which are ISO 9001:2008, ISO 14001:2004 and ISO 22000-certified in API unit at Mahad & Finished Dosage Facility at Pune. We were hit by the global economy meltdown & stock market crash which affected even bigger Pharma companies. Now we are back to business as we look at future with a big vision to reach a 1 Billion $ Industry in 2017. This Award demonstrates our continued fight to defy the odds & march ahead with a strong outlook.”

The other notable awardees include the veterans & stalwarts from the pharmaceutical Industry & medical professions such as Prof. (Dr) V.Mohan, CMD &  Chief Diabetologist, Dr. Mohan's Diabetes Specialties Centre & Madras Diabetes Research Foundation, Mr. Pankaj Patel, Chairman, Zydus Cadila Group, Dr Sanjeev Kanoria, Vice Chairman Austrian Anadi Bank AG & Chairman, Advinia Healthcare Ltd, Mr. Dilip Surana, CMD, Microlabs Ltd, Prof. (Dr.) D. S. Rana, Chairman, Board of Management, Sir Ganga Ram Hospital, Prof. (Dr. B. Soma Raju) Consultant Cardiologist & CMD, Care Hospitals Group,  Shahnaz Husain, CEO - Shahnaz Herbal.

Dr. Datsons Labs Ltd. (formerly known as Aanjaneya Lifecare Ltd.) is a pharmaceutical company. It is engaged in providing provides multi therapeutic product offerings comprising alkaloids, quinine salts, and veterinary active pharmaceutical ingredient and cytotoxic active pharmaceutical ingredient. Its products vertical include bulk drugs, finished dosage forms, herbal medicines, inhalers, lozenges, and products for animal health. The company was founded in 2006 and is based in Mumbai, Maharashtra. Dr. Datsons Labs Ltd is an Research driven pharmaceutical company based in India & is  the third-largest quinine salts manufacturer in the world and among the-largest controlled substances quota in India. Dr. Datsons Labs Ltd enjoys global respect in a competitive business & manufacture Finished Dosage Forms (branded and generic) as well as their raw materials (Active Pharmaceutical Ingredients). Dr. Datsons Labs Ltd transformed lozenges into a Novel Drug Delivery System (NDDS) for common illnesses with two dedicated Lines for Hard Boiled Lozenges. It created an infringing route of synthesis for three complex anti-cancer drugs (Docetaxel, Gemcitabine Hydrochloride and Capcitabine). As a result, it received the  global patents and the prospects of attractive long-term revenues. Dr. Datsons Labs Ltd undertake custom manufacture of APIs and advanced Intermediates CRAMS offering a competitive advantage to its clients over the entire life cycle of the products. Dr. Datsons Labs Ltd undertook the Technology Transfer Services & Dossier Development Services.  Dr.Datsons Labs Ltd in june successfully completed its obligations towards the FCCB Bond Holders for 40 Million USD. There is no Unpaid Debt by the Company towards Bondholders as on July 17, 2014.

Dr.Datsons Labs Ltd has been recently awarded the coveted "Swiss International Quality Certificate". The Swiss Institute for Quality Standards (SIQS) and International Club of Leaders (ICL) have selected dynamic healthcare companies which successfully follows modern management trends and quality philosophy.The Certificate will be presented at the award ceremony taking place on December 30, 2014 in famous Pallavicini Palace in Vienna, Austria.

The Award ceremony will be held at 07.00 PM on 26th December 2014 onwards at the Grand Jade Room of Hotel sahara Star, Mumbai, India to be attended by more than 300 power packed Healthcare Leaders.

Pharmaleaders is  India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry to the statutory Authorities like Ministry of Health & Family Affairs, Dept of Chemicals & Fertilizers, DCGA, FDA & many other institutions to present the pressing demands of the healthcare industry. Network 7 Media Group Media Outfit, a unit of Pharmaleaders, is a result of emergence of an extreme thought process in the form of some of the biggest & exclusive media properties that arose due to the frustration & disappointment of the present status-quo of the society in existence in the form of a careless & extremely insensitive administration of a large set-up. Network 7 Group has continuously strived to expose the misdeeds of the corrupt administrative fabrics or poor legislation or failure of a large entity in corporate governanance. Distinctively standing out of other media initiatives, Network 7 group has been in the forefront of championing the cause of good governance , fair, unbiased & independent reporting in national & international fields. Driven by the objective to address & deliberate some of the burning issues, sometimes neglected causes, Pharmaleaders is pioneering the concept of introducing a fierce democratic process in the form a mass resistance in bringing into the forefront of issues that matter most in the form of digital, printed, published, conclaves, summits & even in blogs & letters shoot out to the authoritative.  Headquartered in Mumbai, Network 7 Group Media Outfit is backed & operated by some of the biggest think-tanks of the contemporary society whose ideas & actions are reflected in the form of editorials & exclusive news findings. Network 7 Group Media is present in the form of digital media production, publications, high-profile international events & healthcare communications

Media Contacts

Unit No.47, 2nd Floor, Aditya Industrial Estate,

CTS No. 1068-C, Plot No. 444(P),

Devrukhkar Wadi,Chincholi Bunder Road, Malad (W),

Mumbai–400064.+ 91 22 42481253, + 91 22 42481259

Mr Anish Khan : ++ 91 9819499475 : [email protected]

Ms Sneha : ++ 91 9930583326  [email protected]  

[email protected]   Web : www.pharmaleaders2014.in